• LLS
  • Team In Training
  • Light The Night
  • Man & Woman of the Year
  • Students of the Year
  • Regatta
  • Hero Squad
  • Lifestyle
  • Big Climb
  • Community
  • Careers at LLS
  • Donate
  • Menu
  • About LLS

    Who We Are

    • Our History
    • Leadership
    • Financials
    • Our Commitment

    Our Mission

    • Research
    • Policy & Advocacy
    • Patient Support

    Contact Us

    • My Chapter
    • Our Regions
    • News Network
    • Partner With LLS
    • Blogs
    • Work at LLS
  • Patients
    & caregivers

    Disease Information

    • Leukemia
    • Lymphoma
    • Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Facts & Statistics
    • Children and Young Adults
    • Newly Diagnosed
    • Managing Your Cancer
    • Treatment
    • Clinical Trials

    Support Resources

    • Contact an Information Specialist
    • Financial Support
    • Online Chats
    • Support Groups
    • Peer-to-Peer Support
    • Caregiver Support
    • Nutrition Consultations
    • LLS Patient Community
    • Podcast
    • Other Helpful Organizations
    • Suggested Reading
    • LLS Health Manager™ App

    Education Resources

    • Information Booklets
    • Webcasts
    • Videos
    • 3D Model Library
    • Drug Listings
    • Blood Cancer Conferences
  • Researchers &
    Healthcare Professionals

    Academic Grants

    • Academic Grant Programs
    • Apply for an Academic Grant

    Therapy Acceleration Program

    • Portfolio
    • The Team
    • Latest News
    • How To Apply

    Resources for HCPs

    • Continuing Education Programs
    • Continuing Medical Education Programs
    • Free Publications
    • Podcast
    • Patient Referral Form
    • Trish Greene Back to School Program
  • How to help

    Ways to Give

    • Donate Online
    • Monthly Giving
    • Donor-Advised Funds
    • Employee Matching Gifts
    • Wills, Trusts, and Annuities
    • Stock Transfer
    • Tribute Gifts
    • Donate by Mail

    Fundraise

    • Fundraising Events
    • Create a Tribute Page
    • Create Your Own Fundraiser

    Volunteer

    • Volunteer

    Advocate

    • Take Action
    • Sign Up to Be an Advocate

    Shop

    • LLS Store
    • Charitable Shopping
  • Donate
  • About LLS
    • Who We Are
      • Our History
      • Leadership
      • Financials
      • Our Commitment
    • Our Mission
      • Research
      • Policy & Advocacy
      • Patient Support
    • Contact Us
      • My Chapter
      • Our Regions
      • News Network
      • Partner With LLS
      • Blogs
      • Work at LLS
  • Patients & caregivers
    • Disease Information
      • Leukemia
      • Lymphoma
      • Myeloma
      • Myelodysplastic Syndromes
      • Myeloproliferative Neoplasms
      • Facts & Statistics
      • Children and Young Adults
      • Newly Diagnosed
      • Managing Your Cancer
      • Treatment
      • Clinical Trials
    • Support Resources
      • Contact an Information Specialist
      • Financial Support
      • Online Chats
      • Support Groups
      • Peer-to-Peer Support
      • Caregiver Support
      • Nutrition Consultations
      • LLS Patient Community
      • Podcast
      • Other Helpful Organizations
      • Suggested Reading
      • LLS Health Manager™ App
    • Education Resources
      • Information Booklets
      • Webcasts
      • Videos
      • 3D Model Library
      • Drug Listings
      • Blood Cancer Conferences
  • Researchers & Healthcare Professionals
    • Academic Grants
      • Academic Grant Programs
      • Apply for an Academic Grant
    • Therapy Acceleration Program
      • Portfolio
      • The Team
      • Latest News
      • How To Apply
    • Resources for HCPs
      • Continuing Education Programs
      • Continuing Medical Education Programs
      • Free Publications
      • Podcast
      • Patient Referral Form
      • Trish Greene Back to School Program
  • How to help
    • Ways to Give
      • Donate Online
      • Monthly Giving
      • Donor-Advised Funds
      • Employee Matching Gifts
      • Wills, Trusts, and Annuities
      • Stock Transfer
      • Tribute Gifts
      • Donate by Mail
    • Fundraise
      • Fundraising Events
      • Create a Tribute Page
      • Create Your Own Fundraiser
    • Volunteer
      • Volunteer
    • Advocate
      • Take Action
      • Sign Up to Be an Advocate
    • Shop
      • LLS Store
      • Charitable Shopping
  • Partners
    • LLS
    • Team In Training
    • Light The Night
    • Man & Woman of the Year
    • Students of the Year
    • Regatta
    • Hero Squad
    • Lifestyle
    • Big Climb
    Community Careers at LLS Language
    • English
    • Spanish
    • Canadian English
    • French Canadian

I am a Patient looking for Disease/Treatment Information related to

En Español
  • Who We Are All Survivor Stories Trish

Trish

NHL Survivor

Hilton Head, SC

  • Print

After being diagnosed with indolent Follicular non-Hodgkins lymphoma (NHL) in 1999, I set off on a course of “Watch and Wait” for two years. This was followed by an idiotype vaccine trial and immunotherapy resulting in some clinical success, but with short-lived remissions.

In 2008, about nine years post diagnosis, I underwent my first R-CHOP chemotherapy. Although I achieved a complete remission with six rounds, my lymphoma was back five months after completion. For the next six years, I continued participating in clinical trials including immunotherapies, immune modulators and check point inhibitors. My disease would often respond or remain stable with treatments. However, it was persistent and eventually would progress.

Chasing the research for novel treatments had me traveling between the two coasts from the University of Pennsylvania to Stanford University in California. Left anemic with heavy fatigue and dealing with numerous side effects, I needed a different kind of treatment. A treatment that would hit the lymphoma hard and offer hope for a sustained remission from a very difficult to treat disease.

In 2014, I enrolled in Novartis’s CAR T-19 experimental gene therapy trial at the University of Pennsylvania. My T-cells were collected and genetically modified to recognize and attack my lymphoma using an HIV vector. Once engineered, I underwent a round of Bendamustine chemotherapy followed a week later with the injection of my new super T-Cells. This therapy at the time, and still today, is a high risk treatment. For me, the need outweighed the risks as my options for continued treatment were very limited.

I was struggling with side effects of a very advanced disease. Immediately following the injection of the engineered T-cells, I developed a high fever and was placed in the ICU. In my time in the ICU, I suffered severe Cytokine Release Syndrome (CRS) similar to a cytokine storm. My reaction was intense and left me very vulnerable fighting for my life with complications of respiratory and kidney failure.

After a lengthy and prolonged critical stay in the ICU for several weeks, I went to a rehab facility to recover. Despite the intense fight I had to endure, the CAR T-19 Engineered T-cells were prolific and successfully eradicated the lymphoma from my body. I am fortunate to have been given access to and benefitted from CAR T-19, a new and proving very promising treatment.

At 21 years from my NHL diagnosis, under the care of a top-notch medical team, I continue to enjoy a 6-plus year remission post CART-19 therapy. The medical advancements with targeted cancer treatments offers great hope to all patients for living longer with better quality of life and ultimately for the possibility of a cure. I am living the good life and see only blue sky on the horizon.

Previous StoryJackson
Next StoryNatalie
Previous StoryJackson
Next StoryNatalie

Follow us

Sign up for latest news

Subscribe

The Leukemia & Lymphoma Society® (LLS) is a global leader in the fight against cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.

The Leukemia & Lymphoma Society is a 501(c)(3) organization, and all monetary donations are tax deductible to the fullest extent allowed by tax laws. Please check with your financial advisor if you have more questions.

  • Privacy Policy
  • Security
  • Copyright
  • Link Policy
  • Disclaimer
  • Public Disclosure
  • Fundraising Disclosure
  • Refund Policy
  • Work for LLS
  • Contact Us